# US 2026/0272642 A1 · Assembly for replacing the tricuspid atrioventricular valve

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0272642 A1
- Document ID: US20260272642A1
- Status: Published application
- Kind: A1
- Application number: 19/668,553
- Filed: 2026-05-05
- Published: 2026-09-17
- Earliest claimed: 2015-11-23
- Assignees: T-Heart SAS
- Applicants: T-Heart SAS
- Inventors: Alain DIBIE
- Web page: https://patentgrep.com/patent/US20260272642A1

## CPC

- A61F 2/2418: {Scaffolds therefor, e.g. support stents}
- A61F 2/2427: {Devices for manipulating or deploying heart valves during implantation}
- A61F 2210/0014: using shape memory or superelastic materials, e.g. nitinol
- A61F 2220/0008: Fixation appliances for connecting prostheses to the body
- A61F 2220/0075: sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
- A61F 2230/0008: elliptical or oval
- A61F 2230/0013: Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
- A61F 2250/0098: radio-opaque, e.g. radio-opaque markers
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

An assembly for the tricuspid orifice of a human heart has an external frame connected to an internal stent carrying a tricuspid valve bioprosthesis and a sealing skirt. The external frame is configured to hold its position in the native tricuspid annulus. The internal stent is connected to the external frame by one or more fixing strands. The sealing skirt covers the interstitial space existing between the external frame and the internal stent. Developments are described which include the use of a deformable region of the frame, various alternative embodiments of the sealing skirt, the use of a frame composed of multiple sub-sections, the use of fixing strands between the stent and the frame and of fixing elements for fixing the assembly to the native tissue, the use of sensors and/or actuators, and also the use of a stent in the inferior vena cava. Method aspects are also described.

## Claims

### Claim at position 1

10-14. (canceled)

### Claim 15

An assembly for a tricuspid orifice of a right side of a human heart having an atrium and a ventricle coupled via a native tricuspid annulus, the assembly comprising
a frame having three zones of different diameters including a first zone having a radially outwardly convex form configured for placement in the ventricle, the first zone having a first diameter, a second zone having a radially outwardly convex form configured for arrangement in the atrium, the second zone having a second diameter, and a third zone configured for arrangement in the valve annulus, third zone disposed between the first and second zones and having a third diameter smaller than the first and second diameters; and
a stent disposed within the frame and configured to carry a tricuspid valve bioprosthesis, the stent having an atrial end, a ventricular end and a midportion therebetween, the stent formed of a plurality of rows of cells including a first row of cells having an elongated hexagonal shape and at least one row of cells of adjacent to the first row of cells having a generally rhombus shape, the stent operatively coupled to the frame only by the one or more fixing strands,
wherein, the frame is configured to engage the native tricuspid annulus and to define a circumferential interstitial space between the frame and the stent over an entire height of the stent,
wherein each of the one or more fixing strands includes a first end and an opposite second end, the first end of each of the one or more fixing strands being coupled to the frame, and the second end of each of the one or more fixing strands being coupled to the stent at a position adjacent to the atrial end of the stent or at the midportion, and
wherein the tricuspid valve bioprosthesis is operable to block flow in a direction from a ventricular end of the frame to an atrial end of the frame.

### Claim 16 (depends on 15)

The assembly of claim 15, wherein the frame has a deformable region configured to hold the assembly in position within the native tricuspid annulus.

### Claim 17 (depends on 15)

The assembly of claim 15, wherein upstream or downstream from the native tricuspid annulus, the frame is configured to reinforce engagement of the assembly to the native tricuspid annulus.

### Claim 18 (depends on 15)

The assembly of claim 15, wherein second diameter is larger than the first diameter.

### Claim 19 (depends on 15)

The assembly of claim 15, wherein each of the one or more fixing strands is made of nitinol.

### Claim 20 (depends on 15)

The assembly of claim 15, further comprising at least one fixing element for fixing the assembly to the native tricuspid annulus.

### Claim 21 (depends on 20)

The assembly of claim 20, wherein at least one of the frame, the stent, the one or more fixing strands, or the fixing element comprises a heat-sensitive material, a shape-memory material, or a shape-memory material that is heat sensitive.

### Claim 22 (depends on 15)

The assembly of claim 15, further comprising a sensor, a radiopaque marker, or both a sensor and a radiopaque marker.

### Claim 23 (depends on 15)

The assembly of claim 15, further comprising an actuator suitable for modifying a structure of the assembly, for adjusting a positioning of a part of the assembly with respect to the native tricuspid annulus, or both for modifying the structure of the assembly and adjusting the positioning of the part of the assembly with respect to the native tricuspid annulus.

### Claim 24 (depends on 15)

The assembly of claim 15, further comprising an anchor stent suitable for deployment within an inferior vena cava, wherein the anchor stent is connected to the frame by a strand made of nitinol.

### Claim 25 (depends on 15)

The assembly of claim 15, wherein the assembly is folded within a catheter for introduction by a percutaneous route.

### Claim 26 (depends on 15)

A method for replacing the tricuspid valve, comprising steps of positioning the assembly of claim 15 in a folded state in a catheter, and introducing and deploying the assembly by a percutaneous route.

### Claim 27 (depends on 15)

The assembly of claim 15, wherein the first end of each of the one or more fixing strands is connected closer to the atrial end than to the ventricular end of the frame.

### Claim 28 (depends on 15)

The assembly of claim 15, wherein the frame extends radially outward with respect to the tricuspid valve bioprosthesis from a middle portion to the atrial end.

### Claim 29 (depends on 15)

The assembly of claim 15, wherein the frame comprises a plurality of independent sub-sections.

### Claim 30 (depends on 29)

The assembly of claim 29, wherein each of the plurality of sub-subsections comprises a loop, such that the loops not being interconnected with each other.

### Claim 31 (depends on 15)

The assembly of claim 15, wherein a diameter of the stent is about 20% smaller than the third diameter.

### Claim 32 (depends on 15)

The assembly of claim 15, wherein the circumferential interstitial space between the frame and the stent remains radially a distance of at least a plurality of millimeters when the assembly is deployed in the native tricuspid annulus.

### Claim 33 (depends on 15)

The assembly of claim 15, wherein the frame has a height greater than the height of the stent.

### Claim 34 (depends on 33)

The assembly of claim 33, wherein the atrial end of the frame extends beyond the atrial end of the stent, and the ventricular end of the frame extends beyond the ventricular end of the stent.

### Claim 35 (depends on 34)

The assembly of claim 34, wherein the height of the frame is between 32 and 45 mm.

### Claim 36 (depends on 15)

The assembly of claim 15, wherein the plurality of rows of cells includes a second row of cells adjacent to the at least one row of cells on a side opposite the first row of cells.

### Claim 37 (depends on 15)

The assembly of claim 15, further comprising a sealing skirt disposed on the assembly, the sealing skirt composed of several sub-sections, of several layers of materials, or of several sub-sections and several layers of material.

### Claim 38 (depends on 37)

The assembly of claim 37, wherein the frame includes an outer wall and an opposite inner wall facing the stent, and the sealing skirt includes an inner portion, an outer portion, and an intra-atrial base portion connecting the inner portion and the outer portion, the inner portion covering a portion of the inner wall, the outer portion covering a portion of the outer wall, and the intra-atrial base portion covering the atrial end of the frame so as to envelope a portion of the frame.
